Sep 17,2021 | Healthcare Services
Autoimmune diseases refer to a body’s abnormal immune responses leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. There are almost 80 types of autoimmune diseases prevailing worldwide of which multiple sclerosis, type 1 diabetes, and rheumatoid arthritis are fairly common. Autoimmune diseases can be divided into two general groups: Organ specific, where the autoantibodies attack a specific organ and Non-organ specific, where the autoantibodies attack multiple organ systems.
Global autoimmune disease diagnostics market is valued approximately USD 3.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2019-2026. As per the American Autoimmune Related Diseases Association, around 50 million Americans currently suffer from autoimmune related disorders. Moreover, the numbers are expected to escalate over the forecast period. The demand for better and precise diagnostic methods, along with the increasing prevalence, is expected to increase over the forecast period. The tests used to diagnose the autoimmune disease include auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate. Rising prevalence of diseases such as rheumatoid arthritis, Hashimoto’s thyroiditis, and presence of favourable government regulations will render significant impact on the autoimmune disease diagnostics market growth.
The COVID-19 outbreak has created a sense of urgency and panic among people globally. The impact of COVID-19 has been positive on the global autoimmune disease diagnostics market. Manufacturers in the autoimmune disease diagnostics market are focusing on developing novel technologies for maximum testing within a minimum period. Further, significant growth is likely to be witnessed with the proper lifting of lockdowns in several cities and resumption of import and export activities worldwide.
A comprehensive analysis of the Global Autoimmune Disease Diagnostic Market offered on Bharatbook, includes the report on the diagnostics market (By Disease, Test Types, Region), impact of COVID-19, vital company profiles, recent developments, strategy & initiatives, and Financial Insights. Key players in the Autoimmune Disease Diagnostics Market are Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, bioMerieux SA, EUROIMMUN AG, Bio-Rad Laboratories and Quest Diagnostics.
To know about the market, please visit Global Autoimmune Disease Diagnostics Market.